(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes were little changed on Monday. The Dow Jones industrial average was up 0.17 percent at 17,632.64, the S&P 500 was up 0.11 percent at 2,051.77 and the Nasdaq Composite was up 0.21 percent at 4,805.846.
** VALSPAR CORP, $103.84, +23.87 pct
** SHERWIN-WILLIAMS CO, $274.23, -5.01 pct
Valspar’s shares are set to open at a record high after rival Sherwin-Williams said on Sunday it would acquire the paint maker in an all-cash deal valued at about $9.3 bln, or $113 per share.
** STARWOOD HOTELS AND RESORTS WORLDWIDE INC, $83.76, +3.96 pct
** MARRIOTT INTERNATIONAL INC, $72.02, -1.56 pct
Marriott said it made a higher offer for Starwood that was accepted by the owner of the Sheraton and Westin hotel brands.
** VALEANT PHARMACEUTICALS INTERNATIONAL INC, $29.49, +9.30 pct
The embattled Canadian drugmaker said Chief Executive Michael Pearson would step down and that the company had appointed activist investor William Ackman to its board.
** IHS INC, $119.62, +8.05 pct
** MARKIT LTD, $32.93, +11.67 pct
U.S. business research provider IHS said it would buy Markit in an all-stock deal valuing the London-based financial data company at about $5.9 billion.
** BIOMARIN PHARMACEUTICAL INC, $77.72, -3.98 pct
BioMarin’s drug met the main goal of reducing a toxic buildup of an amino acid in the blood of patients with a genetic disorder, but did not show benefit in related inattention and mood complications.
** AFFYMETRIX INC, $14.46, -9.57 pct
** THERMO FISHER SCIENTIFIC INC, $139.84, -0.11 pct
Affymetrix, a DNA-based test maker, rejected a $1.5 billion bid by Origin Technologies Corp, supporting the $1.3 bln Thermo Fisher merger deal.
** EXPRESS SCRIPTS HOLDING CO, $69.9, +0.62 pct
** ANTHEM INC, $139.43, -2.28 pct
Health insurer Anthem filed a lawsuit against pharmacy benefit manager Express Scripts to recover damages for pharmacy pricing that was higher than competitive benchmark pricing
** OVASCIENCE INC, $10.7095, +22.53 pct
The fertility treatment’s provider’s stock recorded its best day in 1 1/2 years after Chief Executive Michelle Dipp bought 59,700 shares last week for prices ranging between $7.61-$8.96 per share, according to a regulatory filing
** EAGLE PHARMACEUTICALS INC, $41.1, -5.52 pct
RBC Capital Markets cuts the drugmaker’s price target to $94 from $100 after U.S. FDA on Friday rejected its blood thinner, designed for certain patients undergoing heart surgery.
** INTEL CORP, $32.26, -1.29 pct
Sanford C. Bernstein cut the world’s largest chipmaker’s rating to “underperform” from “market perform” and price target to $26 from $29; Deutsche Bank trimmed to $37 from $38.
** NEW YORK MORTGAGE TRUST INC, $5.025, +7.60 pct
The mortgage REIT declared a regular quarterly dividend of 24 cents per share in cash for the quarter ending March 31 (Compiled by Yashaswini Swamynathan in Bengaluru; Edited by Don Sebastian)